Cargando…

New Insights into the Diversity of the Genus Faecalibacterium

Faecalibacterium prausnitzii is a commensal bacterium, ubiquitous in the gastrointestinal tracts of animals and humans. This species is a functionally important member of the microbiota and studies suggest it has an impact on the physiology and health of the host. F. prausnitzii is the only identifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benevides, Leandro, Burman, Sriti, Martin, Rebeca, Robert, Véronique, Thomas, Muriel, Miquel, Sylvie, Chain, Florian, Sokol, Harry, Bermudez-Humaran, Luis G., Morrison, Mark, Langella, Philippe, Azevedo, Vasco A., Chatel, Jean-Marc, Soares, Siomar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609107/ https://www.ncbi.nlm.nih.gov/pubmed/28970823 http://dx.doi.org/10.3389/fmicb.2017.01790

Ejemplares similares

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic
por: Martín, Rebeca, et al.
Publicado: (2017)

Faecalibacterium: a bacterial genus with promising human health applications
por: Martín, Rebeca, et al.
Publicado: (2023)

Identification of Metabolic Signatures Linked to Anti-Inflammatory Effects of Faecalibacterium prausnitzii
por: Miquel, Sylvie, et al.
Publicado: (2015)

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model
por: Martín, Rebeca, et al.
Publicado: (2015)

Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3
por: Lenoir, Marion, et al.
Publicado: (2020)

Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii
por: Martín, Rebeca, et al.
Publicado: (2018)

Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii
por: Auger, Sandrine, et al.
Publicado: (2022)

Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes
por: Cornuault, Jeffrey K., et al.
Publicado: (2018)

Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models
por: Miquel, S., et al.
Publicado: (2016)

Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
por: Maioli, Tatiani Uceli, et al.
Publicado: (2021)

Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway
por: Breyner, Natalia M., et al.
Publicado: (2017)

A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain
por: Barone, Monica, et al.
Publicado: (2018)

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer
por: Jacouton, Elsa, et al.
Publicado: (2017)

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice
por: Martín, Rebeca, et al.
Publicado: (2016)

Gene co-expression network analysis of the human gut commensal bacterium Faecalibacterium prausnitzii in R-Shiny
por: Auger, Sandrine, et al.
Publicado: (2022)

Oral delivery of pancreatitis‐associated protein by Lactococcus lactis displays protective effects in dinitro‐benzenesulfonic‐acid‐induced colitis model and is able to modulate the composition of the microbiota
por: Breyner, Natalia M., et al.
Publicado: (2019)

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
por: Martín, Rebeca, et al.
Publicado: (2013)

Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
por: Wrzosek, Laura, et al.
Publicado: (2013)

New gene markers for classification and quantification of Faecalibacterium spp. in the human gut
por: Tanno, Hiroki, et al.
Publicado: (2023)

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
por: Bermúdez-Humarán, Luis G, et al.
Publicado: (2011)

Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses
por: Rossi, Oriana, et al.
Publicado: (2016)

Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease
por: Lapiere, Alexia, et al.
Publicado: (2020)

Development of Mucosal Vaccines Based on Lactic Acid Bacteria
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009)

Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria
por: LeBlanc, Jean Guy, et al.
Publicado: (2017)

Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe–Microbe Interactions
por: Martín, Rebeca, et al.
Publicado: (2016)

Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis
por: Carvalho, Rodrigo D. De Oliveira, et al.
Publicado: (2017)

Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models
por: de Moreno de LeBlanc, Alejandra, et al.
Publicado: (2015)

Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model
por: Aubry, Camille, et al.
Publicado: (2015)

Erratum to: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model
por: Aubry, Camille, et al.
Publicado: (2016)

A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe
por: Miquel, Sylvie, et al.
Publicado: (2015)

Anti-tumoral Effects of Recombinant Lactococcus lactis Strain Secreting IL-17A Cytokine
por: Jacouton, Elsa, et al.
Publicado: (2019)

Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis
por: Miyoshi, Anderson, et al.
Publicado: (2006)

Lactococcus lactis engineered to deliver hCAP18 cDNA alleviates DNBS-induced colitis in C57BL/6 mice by promoting IL17A and IL10 cytokine expression
por: Noguès, Esther Borras, et al.
Publicado: (2022)

Utilisation des bactéries lactiques comme vecteurs vaccinaux
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009)

Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties
por: Jacouton, Elsa, et al.
Publicado: (2019)

Faecalibacterium prausnitzii in Differentiated Thyroid Cancer Patients Treated with Radioiodine
por: Fernandes, Ana, et al.
Publicado: (2023)

The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response
por: Martín, Rebeca, et al.
Publicado: (2019)

Faecalibacterium diversity in dairy cow milk
por: Savin, Keith W., et al.
Publicado: (2019)

A new plasmid vector for DNA delivery using lactococci
por: Guimarães, Valeria, et al.
Publicado: (2009)

Metabolic Response of Faecalibacterium prausnitzii to Cell-Free Supernatants from Lactic Acid Bacteria
por: Lebas, Mathilde, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3eeate1jvci1h70tf2hp3cuobf